Innate Pharma(IPHA) - 2024 Q1 - Quarterly Report
Innate Pharma(IPHA)2024-03-21 21:20
EXHIBIT 99.1 Summary of Consolidated Financial Statements and Notes as of December 31, 2023 Consolidated Statements of Financial Position (in thousand euros) | --- | --- | --- | |----------------------------------------------------|-------------------|-------------------| | | December 31, 2023 | December 31, 2022 | | Assets | | | | | | | | Cash and cash equivalents Short-term investments | 70,605 21,851 | 84,225 17,260 | | Trade receivables and others - current | 55,557 | 38,346 | | Total current assets | 1 ...